Chemoinformaics analysis of 1-Methylhexahydro-1H-pyrrolizine
| Molecular Weight | 125.215 | nRot | 0 |
| Heavy Atom Molecular Weight | 110.095 | nRig | 4 |
| Exact Molecular Weight | 125.12 | nRing | 2 |
| Solubility: LogS | -3.558 | nHRing | 2 |
| Solubility: LogP | 3.965 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 24.4619 |
| nHD | 0 | BPOL | 16.7581 |
| QED | 0.223 |
| Synth | 4.282 |
| Natural Product Likeliness | 3.047 |
| NR-PPAR-gamma | 0.964 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.702 |
| CACO-2 | -4.232 |
| MDCK | 0.000023 |
| BBB | 0.018 |
| PPB | 1.00975 |
| VDSS | 1.529 |
| FU | 0.0132593 |
| CYP1A2-inh | 0.724 |
| CYP1A2-sub | 0.286 |
| CYP2c19-inh | 0.9 |
| CYP2c19-sub | 0.721 |
| CYP2c9-inh | 0.888 |
| CYP2c9-sub | 0.983 |
| CYP2d6-inh | 0.577 |
| CYP2d6-sub | 0.275 |
| CYP3a4-inh | 0.917 |
| CYP3a4-sub | 0.277 |
| CL | 4.678 |
| T12 | 0.202 |
| hERG | 0.001 |
| Ames | 0.866 |
| ROA | 0.935 |
| SkinSen | 0.941 |
| Carcinogencity | 0.509 |
| EI | 0.912 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.941 |
| Antiviral | No |
| Prediction | 0.947497 |